HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kyeong-Ok Chang Selected Research

3- (4- hydroxy- 3- (3- oxo- but- 1- enyl)- phenyl)- acrylic acid

2/2005Norovirus proteinase-polymerase and polymerase are both active forms of RNA-dependent RNA polymerase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kyeong-Ok Chang Research Topics

Disease

15Caliciviridae Infections
10/2020 - 02/2011
13Infections
01/2021 - 03/2002
7Gastroenteritis
11/2018 - 02/2005
5Virus Diseases (Viral Diseases)
01/2022 - 09/2009
4COVID-19
01/2022 - 01/2021
4Coronavirus Infections
12/2018 - 05/2015
3Feline Infectious Peritonitis
01/2022 - 01/2018
3Human Influenza (Influenza)
01/2018 - 11/2010
3Disease Progression
02/2012 - 11/2010
2Severe Acute Respiratory Syndrome
01/2022 - 01/2021
2Rotavirus Infections
04/2012 - 12/2011
1Neurologic Manifestations (Neurological Manifestations)
01/2018
1Persistent Infection
11/2017
1Lymphopenia (Lymphocytopenia)
03/2016
1Ascites
03/2016
1Fever (Fevers)
03/2016
1Poliomyelitis (Polio)
01/2016
1Inflammation (Inflammations)
04/2015
1Cognitive Dysfunction
04/2015
1Vesicular Stomatitis
01/2012
1Hepatocellular Carcinoma (Hepatoma)
09/2006

Drug/Important Bio-Agent (IBA)

17Antiviral Agents (Antivirals)IBA
01/2022 - 02/2005
14VaccinesIBA
01/2022 - 09/2006
7Protease Inhibitors (Protease Inhibitor)IBA
01/2022 - 03/2016
4Peptide Hydrolases (Proteases)FDA Link
01/2022 - 12/2018
4Ribavirin (Virazole)FDA LinkGeneric
11/2018 - 09/2007
3EnzymesIBA
01/2022 - 02/2005
3Proteins (Proteins, Gene)FDA Link
01/2020 - 09/2007
3CholesterolIBA
09/2018 - 09/2009
3epigallocatechin gallate (epigallocatechin-3-gallate)IBA
01/2018 - 11/2010
2GC376IBA
01/2022 - 01/2018
2nitazoxanide (NTZ)FDA Link
11/2018 - 01/2018
2Small Interfering RNA (siRNA)IBA
09/2018 - 01/2012
2Pharmaceutical PreparationsIBA
09/2018 - 01/2016
2isoquercitrinIBA
01/2018 - 11/2010
2Bile Acids and Salts (Bile Acids)IBA
05/2014 - 09/2007
2ResveratrolIBA
01/2012 - 11/2010
2PolyphenolsIBA
01/2012 - 11/2010
2RNA (Ribonucleic Acid)IBA
02/2011 - 09/2006
1CyclohexaneIBA
01/2021
1AldehydesIBA
01/2021
1Nucleocapsid ProteinsIBA
01/2020
1Caspase 6IBA
01/2020
1Chlorpromazine (Thorazine)FDA Link
09/2018
1ClathrinIBA
09/2018
1CyclodextrinsIBA
09/2018
1GTP Phosphohydrolases (GTPases)IBA
09/2018
1Dynamins (Dynamin)IBA
09/2018
1Dynamin IIIBA
09/2018
1N'- (3,4- dihydroxybenzylidene)- 3- hydroxy- 2- naphthahydrazideIBA
09/2018
1Nystatin (Mycostatin)FDA LinkGeneric
09/2018
1PDI inhibitor 16f16IBA
01/2018
1juniferdinIBA
01/2018
1Protein Disulfide-IsomerasesIBA
01/2018
1PACMA-31IBA
01/2018
1GuanineIBA
11/2017
1calcineurin phosphataseIBA
11/2017
1AcidsIBA
01/2016
1Amyloid beta-PeptidesIBA
04/2015
1Adenosine Monophosphate (AMP)IBA
04/2015
1Adenosine Triphosphate (ATP)IBA
04/2015
1Flavin Mononucleotide (FMN)IBA
04/2015
1AMP-Activated Protein KinasesIBA
04/2015
1Cathepsin LIBA
09/2014
1Acyl Coenzyme A (Acyl CoA)IBA
05/2012
1triacsin CIBA
04/2012
1Immunologic Adjuvants (Immunologic Adjuvant)IBA
02/2012
1Interleukin-4 (Interleukin 4)IBA
02/2012
1CytokinesIBA
02/2012
1Interleukin-1beta (Interleukin 1 beta)IBA
02/2012
1UbiquitinIBA
01/2012
1degrasynIBA
01/2012
1Triglycerides (Triacylglycerol)IBA
12/2011
1LipidsIBA
12/2011
1NanogelsIBA
02/2011
1InterferonsIBA
02/2011
1Neuraminidase (Sialidase)IBA
11/2010
1Interleukin-10 (Interleukin 10)IBA
03/2009
1Interferon-alpha (Interferon Alfa)IBA
09/2007
13- (4- hydroxy- 3- (3- oxo- but- 1- enyl)- phenyl)- acrylic acidIBA
02/2005
1Rotavirus VaccinesIBA
09/2002
1Immunoglobulin A (IgA)IBA
09/2002
1AntibodiesIBA
09/2002
1AntigensIBA
03/2002
1Viral RNAIBA
03/2002

Therapy/Procedure

17Therapeutics
12/2021 - 09/2007
1Transplantation
11/2017
1Microspheres (Microsphere)
02/2012
1Oral Administration
12/2011